A Multi-Center, Randomized, Double-Blind, Placebo Controlled Study of the Efficacy and Safety of Rilonacept for the Prophylaxis of Gout Flares During the Initiation of Allopurinol Therapy.

Trial Profile

A Multi-Center, Randomized, Double-Blind, Placebo Controlled Study of the Efficacy and Safety of Rilonacept for the Prophylaxis of Gout Flares During the Initiation of Allopurinol Therapy.

Completed
Phase of Trial: Phase III

Latest Information Update: 04 May 2017

At a glance

  • Drugs Rilonacept (Primary)
  • Indications Gout
  • Focus Registrational; Therapeutic Use
  • Acronyms PRE-SURGE-2
  • Most Recent Events

    • 09 Jun 2012 Results from a pooled analysis comparing outcomes in patients with and without tophi and/or polyarticular disease presented at the 13th Annual Congress of the European League Against Rheumatism.
    • 09 Jun 2012 Pooled analysis presented at the 13th Annual Congress of the European League Against Rheumatism.
    • 31 Mar 2012 Status changed from recruiting to completed as reported by EudraCT.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top